Levetiracetam Aurobindo (Levetiracetam)

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilises neuronal membranes and reduces abnormal neuronal excitability, thereby decreasing the likelihood of seizure initiation and propagation.

The dosage of levetiracetam is individualized and set by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Patients should follow the exact dosing instructions provided by their healthcare provider and not adjust the dose on their own.

The safety of levetiracetam in pregnancy and lactation is not fully established. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and monitoring strategies with their physician.

To order Levetiracetam Aurobindo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Levetiracetam is distinguished by its unique SV2A binding mechanism, which generally results in fewer drug‑drug interactions compared with enzyme‑inducing agents such as carbamazepine or phenytoin. It is often chosen for its broad spectrum of activity across seizure types and its relatively favorable tolerability profile.

Levetiracetam tablets should be stored at room temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Levetiracetam is taken orally, usually as a tablet or oral solution, with or without food. The exact administration schedule—once daily, twice daily, or more—depends on the prescriber’s recommendation and the individual patient’s therapeutic needs.

Serious risks include severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, and neuropsychiatric events such as suicidal thoughts, severe depression, or aggressive behaviour. Patients should seek immediate medical attention if they experience any of these symptoms.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is also advised for patients with severe renal impairment, as dose adjustments are required, and for those with a history of serious psychiatric disorders.